Danaher | DHR - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Abbott USD 9.31B 104M 2026-03
Agilent USD 1.44B 27M 2025-12
Align Technology USD 862.03M 39.18M 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Bruker USD 813.2M 87.7M 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 1.32B 895M 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
ESCO Technologies USD 1.59B 1.33B 2026-03
Fortive USD 877.7M 19.3M 2026-03
Henry Schein USD 3.17B 77M 2026-03
Illumina USD 852M 51M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Keysight Technologies USD 1.28B 12M 2026-03
Laboratory Of America USD 3.13B 6.3M 2026-03
Medtronic USD 7.28B 16M 2025-12
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Quidel USD 1.85B 1.09B 2026-03
Repligen USD 174.27M 3.67M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Roper Industries USD 1.53B 55.4M 2026-03
Stryker USD 4.92B 284M 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Waters USD 1.12B 457.15M 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03